Trump’s tariff pivot: Signs order to exempt over 45 import categories-From gold, nickel, pharma, see what’s covered His latest order identifies more than 45 categories for zero import tariffs from “aligned partners” who clinch framework pacts to… 2 days agoSeptember 6, 2025
The truth behind India’s top 3 fastest-growing companies With increasing government policy support, innovation, and digitalisation, many Indian businesses are growing at a fast pace. Here are three… 6 days agoSeptember 1, 2025
India’s contract drugs manufacturing set to grow at 18%: Jefferies India’s $3 bn contract research, development and manufacturing (CRDMO) sector is set to grow at 18% CAGR till FY30, says… 2 weeks agoAugust 26, 2025
Explainer: Why data exclusivity in pharma could be risky Allowing data exclusivity would prevent the drug regulator — Central Drugs Standard Control Organisation — from granting marketing approval for… 2 weeks agoAugust 26, 2025
July exports up 7.3% on US sales, trade deficit hits 8-month high India’s July exports rose 7.3% to $37.24 bn on strong US sales, but imports surged, widening the trade deficit to… 3 weeks agoAugust 14, 2025
Growth prescription: The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty… 4 weeks agoAugust 11, 2025
‘Strong guardrails key to GenAI success,’ says Tarun Mathur Tarun Mathur, CTO of Indegene, on how pharma firms can responsibly scale GenAI, the guardrails needed for compliance, and emerging… 4 weeks agoAugust 10, 2025
Aurobindo Pharma: Elara Capital lists 3 growth drivers for FY26 Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for… 1 month agoAugust 6, 2025
India at disadvantage as Trump imposes 25% tariff – Pharma, textiles, auto parts, who’s most at risk? The US has imposed a steep 25 per cent tariff on Indian goods, targeting key export sectors like textiles, diamonds,… 1 month ago
Sun Pharma slides 6% but Motilal Oswal recommends Buy: 3 reasons why Sun Pharma slides 6% after weak Q1 FY26 results, but Motilal Oswal still recommends Buy—discover the three reasons to consider… 1 month ago
White House confirms April tariff exemptions for key sectors to continue: Copper, pharma, steel in focus The White House has extended key tariff exemptions under Executive Order 14257, shielding sectors like copper, steel, pharmaceuticals, and auto… 1 month ago
Trump tariff impact on Pharma: Breathing easy or trapped in crosshair ahead? Here’s how stocks are reacting Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what… 1 month agoJuly 31, 2025
Markets shrug off tariff shocker, Nifty hits 24,900 led by HUL, Jio Finance; Experts call it Trump ‘posturing’, share key advice Markets today at open, July 31: Markets plunge after Trump’s 25% tariff on Indian imports; track key losers and gainers… 1 month ago
25% tariff bomb: India’s electronics, pharma, textiles to be worst hit – Full list US President Donald Trump has announced a 25 per cent tariff and secondary sanctions on Indian goods starting August 1.… 1 month ago
Jubilant Pharmova Q1 profit slumps 78.66% on high base, revenue rises — What is the company betting on for future growth? Jubilant Pharmova reported a 78.66 per cent decline in Q1 profit due to a high base effect, even as revenue… 1 month ago
Upcoming earnings: From ITC, IndusInd Bank to BEL, Swiggy, more than 50 companies set to announce Q1 results this week As Q1FY26 earnings season heats up, Swiggy, Mahindra & Mahindra, ITC, Tata Power, Sun Pharma, UPL, and Maruti Suzuki are… 1 month agoJuly 28, 2025
Can stem cell therapies cure chronic diseases? Dr Gaurav Kharya on future of personalised medicines Dr Gaurav Kharya of Indraprastha Apollo Hospitals explains how stem cell therapies could potentially cure severe Type 1 diabetes. Explore… 1 month agoJuly 26, 2025
Cipla Q1FY26: Net profit rises 10% to Rs 1,298 crore Cipla reports 10 per cent rise in net profit to Rs 1,298 crore for Q1FY26 with India business crossing Rs… 1 month agoJuly 25, 2025
Trump holds Mercedes, BMW ‘hostage,’ warns potential European car sale ban in US if drug companies don’t…
